You are here: Industry Insights > MCC

News List

Microcrystalline Cellulose in Solid Dosage Forms: A Guide to Quality and Sourcing Saher Haider
February 19, 2025
This article overviews microcrystalline cellulose (MCC), covering its properties, production, uses, quality, sourcing, and importance in pharma.
Exicure Provides Interim Results from Ongoing Phase 1b/2 Clinical Trial of Cavrotolimod (AST-008) drugs
August 10, 2021
Exicure, Inc. (NASDAQ: XCUR), a pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) technology, is providing an update on the Phase 1b/2 clinical trial of cavrotolimod (AST-008) (NCT03684785).
Anixa Biosciences, Moffitt Cancer Center File IND Application for Ovarian Cancer CAR-T Therapy americanpharmaceuticalreview
March 25, 2021
Anixa Biosciences announced an IND (Investigational New Drug) application for its ovarian cancer CAR-T (Chimeric Antigen Receptor T-cell) therapy has been filed with the U.S. Food and Drug Administration (FDA).
Merck to submit CDF proposal for cancer drug pharmaceutical-technology
November 30, 2017
The UK National Institute for Health and Care Excellence (NICE) has invited Merck to submit a Cancer Drugs Fund (CDF) proposal for its immunotherapy, avelumab, for the treatment of patients with Merkel cell carcinoma (MCC).